Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Surgery in Pediatric Crohn's Disease: Indications, Timing and Post-Operative Management

  • Kim, Seung (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine)
  • Received : 2017.02.04
  • Accepted : 2017.03.13
  • Published : 2017.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Pediatric onset Crohn's disease (CD) tends to have complicated behavior (stricture or penetration) than elderly onset CD at diagnosis. Considering the longer duration of the disease in pediatric patients, the accumulative chance of surgical treatment is higher than in adult onset CD patients. Possible operative indications include perianal CD, intestinal stricture or obstruction, abdominal abscess or fistula, intestinal hemorrhage, neoplastic changes and medically untreatable inflammation. Growth retardation is an operative indication only for pediatric patients. Surgery can affect a patient's clinical course, especially for pediatric CD patient who are growing physically and mentally, so the decision should be made by careful consideration of several factors. The complex and diverse clinical conditions hinder development of a systemized treatment algorithm. Therefore, timing of surgery in pediatric CD patients should be determined with individualized approach by an experienced and well organized multidisciplinary inflammatory bowel disease team. Best long-term outcomes will require proactive post-operative monitoring and therapeutic modifications according to the conditions.

Keywords

References

  1. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. https://doi.org/10.1002/ibd.21493
  2. Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis 2013;45:89-94. https://doi.org/10.1016/j.dld.2012.09.005
  3. El-Asmar K, El-Shafei E, Abdel-Latif M, AbouZeid A, El-Behery M. Surgical aspects of inflammatory bowel diseases in pediatric and adolescent age groups. Int J Colorectal Dis 2016;31:301-5. https://doi.org/10.1007/s00384-015-2388-2
  4. Na SY, Shim JO. Biological therapy for inflammatory bowel disease in children. Pediatr Gastroenterol Hepatol Nutr 2012;15:13-8. https://doi.org/10.5223/pghn.2012.15.1.13
  5. Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol 2012;107:579-88. https://doi.org/10.1038/ajg.2011.448
  6. Gupta N, Cohen SA, Bostrom AG, Kirschner BS, Baldassano RN, Winter HS, et al. Risk factors for initial surgery in pediatric patients with Crohn's disease. Gastroenterology 2006;130:1069-77. https://doi.org/10.1053/j.gastro.2006.02.003
  7. Hatch QM, Ratnaparkhi R, Althans A, Keating M, Neupane R, Nishtala M, et al. Is modern medical management changing ultimate patient outcomes in inflammatory bowel disease? J Gastrointest Surg 2016;20:1867-73. https://doi.org/10.1007/s11605-016-3275-z
  8. Kim HJ, Oh SH, Kim DY, Lee HS, Park SH, Yang SK, et al. Clinical characteristics and long-term outcomes of paediatric Crohn's disease: a single-centre experience. J Crohns Colitis 2017;11:157-64. https://doi.org/10.1093/ecco-jcc/jjw146
  9. Seifarth C, Kreis ME, Grone J. Indications and specific surgical techniques in Crohn's disease. Viszeralmedizin 2015;31:273-9.
  10. Scott N, Hughes L. Timing of ileocolonic resection for symptomatic Crohn's disease--the patient's view. Gut 1994;35:656-7. https://doi.org/10.1136/gut.35.5.656
  11. Bhakta A, Tafen M, Glotzer O, Ata A, Chismark AD, Valerian BT, et al. Increased incidence of surgical site infection in IBD patients. Dis Colon Rectum 2016;59:316-22. https://doi.org/10.1097/DCR.0000000000000550
  12. Hansen LF, Jakobsen C, Paerregaard A, Qvist N, Wewer V. Surgery and postoperative recurrence in children with Crohn disease. J Pediatr Gastroenterol Nutr 2015;60:347-51. https://doi.org/10.1097/MPG.0000000000000616
  13. Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, et al. Development of the Crohn's disease digestive damage score, the Lemann score. Inflamm Bowel Dis 2011;17:1415-22. https://doi.org/10.1002/ibd.21506
  14. Keljo DJ, Markowitz J, Langton C, Lerer T, Bousvaros A, Carvalho R, et al. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis 2009;15:383-7. https://doi.org/10.1002/ibd.20767
  15. Baillie CT, Smith JA. Surgical strategies in paediatric inflammatory bowel disease. World J Gastroenterol 2015;21:6101-16. https://doi.org/10.3748/wjg.v21.i20.6101
  16. Alos R, Hinojosa J. Timing of surgery in Crohn's disease: a key issue in the management. World J Gastroenterol 2008;14:5532-9. https://doi.org/10.3748/wjg.14.5532
  17. de Zoeten EF, Pasternak BA, Mattei P, Kramer RE, Kader HA. Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement. J Pediatr Gastroenterol Nutr 2013;57:401-12. https://doi.org/10.1097/MPG.0b013e3182a025ee
  18. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB; American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn's disease. Gastroenterology 2003;125:1508-30. https://doi.org/10.1016/j.gastro.2003.08.025
  19. Halme L, Sainio AP. Factors related to frequency, type, and outcome of anal fistulas in Crohn's disease. Dis Colon Rectum 1995;38:55-9. https://doi.org/10.1007/BF02053858
  20. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 2003;9:98-103. https://doi.org/10.1097/00054725-200303000-00003
  21. Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 2016;388:1281-90. https://doi.org/10.1016/S0140-6736(16)31203-X
  22. Strong S, Steele SR, Boutrous M, Bordineau L, Chun J, Stewart DB, et al. Clinical practice guideline for the surgical management of Crohn's disease. Dis Colon Rectum 2015;58:1021-36. https://doi.org/10.1097/DCR.0000000000000450
  23. Di Nardo G, Oliva S, Passariello M, Pallotta N, Civitelli F, Frediani S, et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, doubleblind, controlled trial. Gastrointest Endosc 2010;72:1201-8. https://doi.org/10.1016/j.gie.2010.08.003
  24. Hagel AF, Hahn A, Dauth W, Matzel K, Konturek PC, Neurath MF, et al. Outcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn's disease. Surg Endosc 2014;28:2966-72. https://doi.org/10.1007/s00464-014-3559-x
  25. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991;214:230-8; discussion 238-40. https://doi.org/10.1097/00000658-199109000-00006
  26. Pfefferkorn MD, Marshalleck FE, Saeed SA, Splawski JB, Linden BC, Weston BF. NASPGHAN clinical report on the evaluation and treatment of pediatric patients with internal penetrating Crohn disease: intraabdominal abscess with and without fistula. J Pediatr Gastroenterol Nutr 2013;57:394-400. https://doi.org/10.1097/MPG.0b013e31829ef850
  27. Garcia JC, Persky SE, Bonis PA, Topazian M. Abscesses in Crohn's disease: outcome of medical versus surgical treatment. J Clin Gastroenterol 2001;32:409-12. https://doi.org/10.1097/00004836-200105000-00010
  28. Kim KJ, Han BJ, Yang SK, Na SY, Park SK, Boo SJ, et al. Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn's disease. Dig Liver Dis 2012;44:723-8. https://doi.org/10.1016/j.dld.2012.03.010
  29. Papi C, Gili L, Tarquini M, Antonelli G, Capurso L. Infliximab for severe recurrent Crohn's disease presenting with massive gastrointestinal hemorrhage. J Clin Gastroenterol 2003;36:238-41. https://doi.org/10.1097/00004836-200303000-00011
  30. Podugu A, Tandon K, Castro FJ. Crohn's disease presenting as acute gastrointestinal hemorrhage. World J Gastroenterol 2016;22:4073-8. https://doi.org/10.3748/wjg.v22.i16.4073
  31. Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, et al. Nutritional status and growth in pediatric Crohn's disease: a population-based study. Am J Gastroenterol 2010;105:1893-900. https://doi.org/10.1038/ajg.2010.20
  32. Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis 2014;8:1179-207. https://doi.org/10.1016/j.crohns.2014.04.005
  33. Malik S, Mason A, Bakhshi A, Young D, Bishop J, Garrick V, et al. Growth in children receiving contemporary disease specific therapy for Crohn's disease. Arch Dis Child 2012;97:698-703. https://doi.org/10.1136/archdischild-2011-300771
  34. Singh Ranger G, Lamparelli MJ, Aldridge A, Chong SK, Mitton SG, Albanese A, et al. Surgery results in significant improvement in growth in children with Crohn's disease refractory to medical therapy. Pediatr Surg Int 2006;22:347-52. https://doi.org/10.1007/s00383-006-1664-1
  35. Yu JX, East JE, Kaltenbach T. Surveillance of patients with inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2016;30:949-58. https://doi.org/10.1016/j.bpg.2016.10.014
  36. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:746-74, 774.e1-4. https://doi.org/10.1053/j.gastro.2009.12.035
  37. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-95. https://doi.org/10.1056/NEJMoa0904492
  38. Hyams JS, Griffiths A, Markowitz J, Baldassano RN, Faubion WA Jr, Colletti RB, et al. Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. Gastroenterology 2012;143:365-74.e2. https://doi.org/10.1053/j.gastro.2012.04.046
  39. Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther 2012;35:625-33. https://doi.org/10.1111/j.1365-2036.2012.05002.x
  40. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63. https://doi.org/10.1016/0016-5085(90)90613-6
  41. Hashash JG, Regueiro MD. The evolving management of postoperative Crohn's disease. Expert Rev Gastroenterol Hepatol 2012;6:637-48. https://doi.org/10.1586/egh.12.45
  42. Regueiro M. Management and prevention of postoperative Crohn's disease. Inflamm Bowel Dis 2009;15:1583-90. https://doi.org/10.1002/ibd.20909
  43. Domenech E, Manosa M, Lobaton T, Cabre E. Optimizing post-operative Crohn's disease treatment. Ann Gastroenterol 2014;27:313-9.
  44. Danese S. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 2012;61:918-32. https://doi.org/10.1136/gutjnl-2011-300904
  45. Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015;110:1324-38. https://doi.org/10.1038/ajg.2015.233
  46. de Groof EJ, Buskens CJ, Bemelman WA. Single-port surgery in inflammatory bowel disease: a review of current evidence. World J Surg 2016;40:2276-82. https://doi.org/10.1007/s00268-016-3509-y
  47. Smith NP, Ba'ath ME, Perry D, Morgan LE, Lamont GL, Baillie CT. BAPS UK inflammatory bowel disease surgical practice survey. J Pediatr Surg 2007;42:296-9. https://doi.org/10.1016/j.jpedsurg.2006.10.002

Cited by

  1. Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target vol.21, pp.1, 2018, https://doi.org/10.5223/pghn.2018.21.1.1
  2. Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study vol.68, pp.1, 2017, https://doi.org/10.1097/mpg.0000000000002119
  3. Medical staff tend to underestimate the quality of life in children and adolescents with inflammatory bowel disease vol.108, pp.1, 2017, https://doi.org/10.1111/apa.14498
  4. Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease vol.22, pp.4, 2017, https://doi.org/10.5223/pghn.2019.22.4.358
  5. Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease vol.15, pp.4, 2017, https://doi.org/10.5009/gnl20134
  6. Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? vol.24, pp.6, 2017, https://doi.org/10.5223/pghn.2021.24.6.564